A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer.
10.3779/j.issn.1009-3419.2010.04.18
- Author:
Ramaswamy GOVINDAN
1
Author Information
1. Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA. rgovinda@im.wustl.edu
- Publication Type:Journal Article
- MeSH:
Carcinoma, Non-Small-Cell Lung;
drug therapy;
metabolism;
Humans;
Lung Neoplasms;
drug therapy;
metabolism;
Models, Biological;
Protein Kinase Inhibitors;
therapeutic use;
Receptor, Epidermal Growth Factor;
antagonists & inhibitors;
Receptor, ErbB-2;
antagonists & inhibitors
- From:
Chinese Journal of Lung Cancer
2010;13(4):363-369
- CountryChina
- Language:Chinese
